Lantus Dose Calculator

Estimate a starting dose of insulin glargine U-100 from body weight, with the titration step used to adjust it against fasting glucose.

Starting doses are prescriber decisions. This estimates a published starting range; your prescriber sets the actual dose and the titration schedule.

🌙 Lantus Starting Dose

What Lantus is

Lantus is insulin glargine at U-100 — 100 units per millilitre — and it was the first of the long-acting analogues to give a genuinely flat 24-hour profile. It begins working over 1 to 2 hours, has no pronounced peak, and lasts around 24 hours, which is what makes once-daily basal coverage possible.

That absence of a peak is the clinically important property. NPH, the intermediate insulin it largely replaced for basal use, peaks several hours after injection, which produces a predictable window of hypoglycemia risk. A flat profile removes that window.

PropertyLantus (glargine U-100)
ConcentrationU-100 (100 units/mL)
Onset1–2 hours
PeakNone pronounced
Duration~24 hours
DosingOnce daily, same time each day
In-use window28 days at room temperature

Starting and titrating

For an insulin-naive Type 2 patient, basal insulin is conventionally started either at 0.1–0.2 units per kg per day or as a flat 10 units once daily. Both appear in guidance; the fixed start is simpler and the weight-based one is better matched to larger or more insulin-resistant patients.

For Type 1, basal is a share of the total daily dose rather than a standalone calculation — commonly around half of a TDD that itself starts near 0.5 u/kg/day. Our dose-by-weight calculator works through the full split.

Titration is against fasting glucose, because that is what basal insulin controls. The common algorithm adds 2 units every 3 days until fasting readings reach target; a more cautious version adds 1 unit every 3 to 5 days and is preferable for anyone with hypoglycemia unawareness or a history of nocturnal lows. The three-day interval is not arbitrary — it takes that long for a dose change to show its full effect.

Where it sits against the alternatives

Glargine U-100 is the reference point most other basals are described against, so it is worth knowing how they differ.

InsulinDurationConcentrationDistinguishing feature
Lantus (glargine)~24 hU-100The flat-profile baseline
Toujeo (glargine)up to 36 hU-300Same molecule, three times concentrated, flatter still
Tresiba (degludec)up to 42 hU-100 / U-200Longest duration; flexible injection timing
Levemir (detemir)~12–24 hU-100Sometimes twice daily; 42-day in-use window
NPH~12–18 hU-100Has a peak; usually twice daily

Biosimilar glargines — Basaglar, Semglee, Rezvoglar — are U-100 glargine like Lantus and are dosed on the same basis, though switching is still a prescriber decision.

Limitations & Safety Notes

  • Starting doses are published ranges, not prescriptions. Actual requirement emerges over weeks of titration against fasting glucose.
  • Basal insulin does not cover meals. Persistent post-meal highs indicate a mealtime insulin problem, not a basal one.
  • A high fasting reading is not always insufficient basal — dawn phenomenon and post-hypoglycemic rebound look identical on a morning meter, and raising basal in either case risks nocturnal hypoglycemia.
  • Reduced kidney function lowers insulin requirement because injected insulin is cleared renally.
  • Glargine products are not interchangeable unit-for-unit with degludec or with glargine U-300. Switching requires a dose review.

Frequently Asked Questions

For an insulin-naive Type 2 patient the usual start is 0.1–0.2 units per kg per day, or a flat 10 units once daily. In Type 1, basal is roughly half of a total daily dose that itself starts near 0.5 u/kg. Both are starting points that get titrated against fasting glucose.

Once daily at the same time each day. Which time matters less than consistency, because the profile is flat across 24 hours — but moving the injection around undermines that.

The common algorithm is 2 units every 3 days until fasting glucose reaches target, or 1 unit every 3–5 days if you are prone to lows. Faster than that outruns the time a change needs to show its full effect.

Same molecule, different concentration. Toujeo is glargine at U-300 — three times as concentrated — which changes the absorption profile, making it flatter and longer-acting. They are not interchangeable unit-for-unit.

No. Glargine must not be mixed or diluted with any other insulin; doing so alters its action profile. It is given as a separate injection.

28 days at room temperature below 86°F, after which it should be discarded even if insulin remains. Our expiration date calculator works out the exact date.

Sources

  1. American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes — 2026. Diabetes Care. 2026;49(Suppl 1):S183. Link — basal initiation and titration principles
  2. Endotext / NCBI Bookshelf. Inpatient Diabetes Management. Link — weight-based basal dosing ranges
  3. Novo Nordisk / manufacturer storage and stability references for basal insulin analogues. Link — in-use windows for comparison

Last reviewed: July 2026

Educational tool only. Insulin doses are prescribed and titrated by your care team. Brand names are the trademarks of their manufacturers; this site is independent and not affiliated with them.